Brief: Promore Pharma Adjusts Plans For PXL01 In North America
Jan 2 (Reuters) - Promore Pharma Ab PROMO.ST :
* PROMORE PHARMA ADJUSTS PLANS FOR PXL01 IN NORTH AMERICA
* WILL CONTINUE TO SEEK FUNDING FOR A PHASE III CLINICAL
TRIAL ON
PXL01 IN NORTH AMERICA
Source text for Eikon: ID:nWkr3wFpc7
Further company coverage: PROMO.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on PMD Device Solutions AB
See all newsBrief: PMD Device Solutions Files For Bankruptcy
Brief: PMD Device Solutions Q3 EBITDA Loss Widens To SEK 8.9 Mln
Brief: Pmd Device Solutions Completes Sale Of Coala Life Monitor
Brief: PMDS’ Largest Shareholder Requests EGM To Appoint New Non-Executive Directors
Brief: PMDS Says RespiraSense Technology Demonstrates Capability In Predicting 7-Day Mortality